{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:21:59Z","timestamp":1791174119060,"version":"4.1.0"},"reference-count":204,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Although psychiatric drug withdrawal syndromes have been recognized since the 1950s \u2013 recent studies confirm antidepressant withdrawal syndrome incidence upwards of 40% \u2013 medical information about how to safely go off the drugs has been lacking. To fill this gap, over the last 25\u2009years, patients have developed a robust Internet-based subculture of peer support for tapering off psychiatric drugs and recovering from withdrawal syndrome. This account from the founder of such an online community covers lessons learned from thousands of patients regarding common experiences with medical providers, identification of adverse drug reactions, risk factors for withdrawal, tapering techniques, withdrawal symptoms, protracted withdrawal syndrome, and strategies to cope with symptoms, in the context of the existing scientific literature.<\/jats:p>","DOI":"10.1177\/2045125321991274","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T19:56:10Z","timestamp":1615924570000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":68,"title":["What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4094-6744","authenticated-orcid":false,"given":"Adele","family":"Framer","sequence":"first","affiliation":[{"name":"SurvivingAntidepressants.org, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"237","article-title":"Antidepressant withdrawal phenomena","volume":"19","author":"Dilsaver SC","year":"1984","unstructured":"Dilsaver SC, Greden JF. Antidepressant withdrawal phenomena. Biol Psychiatry 1984; 19: 237\u2013256.","journal-title":"Biol Psychiatry"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.08.027"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18060692"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000370338"},{"key":"e_1_3_3_6_2","unstructured":"Benzobuddies.org. Benzodiazepine withdrawal support and information https:\/\/web.archive.org\/web\/20041009112234\/http:\/\/www.benzobuddies.org\/ (2004 accessed 27 December 2020)."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1192\/pb.29.6.219"},{"key":"e_1_3_3_8_2","unstructured":"The Effexor Activist https:\/\/web.archive.org\/web\/20070329050732\/http:\/\/theeffexoractivist.org:80\/ (2007 accessed 11 January 2021)."},{"key":"e_1_3_3_9_2","unstructured":"Groenendijk C. Antidepressants facts side-effects safety. Antidepressantsfacts.com https:\/\/web.archive.org\/web\/20041213010139\/http:\/\/www.antidepressantsfacts.com:80\/ (2004 accessed 26 December 2020)."},{"key":"e_1_3_3_10_2","unstructured":"Paxilprogress.org https:\/\/web.archive.org\/web\/20041129012832\/http:\/\/www.paxilprogress.org\/forums\/ (2004 accessed 26 December 2020)."},{"key":"e_1_3_3_11_2","unstructured":"QuitPaxil.org. Paxil withdrawal support https:\/\/web.archive.org\/web\/20011012083247\/http:\/\/www.quitpaxil.org\/ (2001 accessed 26 December 2020)."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320981174"},{"key":"e_1_3_3_13_2","unstructured":"Nimmo R. Benzodiazepine addiction withdrawal & recovery. Benzo.org.uk https:\/\/web.archive.org\/web\/20010204190600\/http:\/\/benzo.org.uk:80\/ (2001 accessed 27 December 2020)."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000341178"},{"key":"e_1_3_3_15_2","unstructured":"Aviv R. The challenge of going off psychiatric drugs. The New Yorker https:\/\/www.newyorker.com\/magazine\/2019\/04\/08\/the-challenge-of-going-off-psychiatric-drugs (2019 accessed 13 February 2020)."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320932452"},{"key":"e_1_3_3_17_2","first-page":"175","article-title":"SSRI and SNRI withdrawal symptoms reported on an internet forum","volume":"29","author":"Stockmann T","year":"2018","unstructured":"Stockmann T, Odegbaro D, Timimi S et al. SSRI and SNRI withdrawal symptoms reported on an internet forum. Int J Risk Saf Med 2018; 29: 175\u2013180.","journal-title":"et al."},{"key":"e_1_3_3_18_2","unstructured":"Witt-Doerring J Shorter D Kosten T. Online communities for drug withdrawal: what can we learn? Psychiatric Times https:\/\/www.psychiatrictimes.com\/article\/online-communities-drug-withdrawal-what-can-we-learn (2018 accessed 12 February 2020)."},{"key":"e_1_3_3_19_2","unstructured":"Phelps J. Deprescribing in psychiatry - psychopharmacology institute. Psychopharmacology Institute https:\/\/psychopharmacologyinstitute.com\/section\/deprescribing-in-psychiatry-2330-4422 (2019 accessed 12 February 2020)."},{"key":"e_1_3_3_20_2","unstructured":"Anderson R. Learning from ePatient (scholar)s. ACM Interactions https:\/\/interactions.acm.org\/blog\/view\/learning-from-epatient-scholars (2013 accessed 31 October 2020)."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1990"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020206"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.2196\/13022"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-019-0782-3"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2429"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145702002870"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v03n0404"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000371865"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049732317728053"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2011.10.003"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m754"},{"key":"e_1_3_3_32_2","author":"Food and Drug Administration","year":"2001","unstructured":"Food and Drug Administration. Paxil prescribing information, attachment to FDA approval letter NDA 20-031\/S-029. FDA Approval Letter, US Food and Drug Administration, 2001.","journal-title":"Paxil prescribing information, attachment to FDA approval letter NDA 20-031\/S-029"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19950301-11"},{"key":"e_1_3_3_34_2","unstructured":"Semel Institute for Neuroscience and Human Behavior. UCLA dual diagnosis program. Post-Acute Withdrawal Syndrome (PAWS) https:\/\/www.semel.ucla.edu\/dual-diagnosis-program\/News_and_Resources\/PAWS (2019 accessed 11 December 2019)."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012288145-9\/50103-0"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320980573"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz025."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.7507"},{"key":"e_1_3_3_39_2","first-page":"13","volume-title":"Behavioral health, United States, 2012","author":"Substance Abuse and Mental Health Services Administration","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration. Behavioral health, United States, 2012. HHS Publication No. (SMA) 13-4797, Rockville, MD: SAMHSA, 2013."},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19com13075"},{"key":"e_1_3_3_41_2","unstructured":"Simons P. Peer-support groups were right guidelines were wrong: Dr. Mark Horowitz on tapering off antidepressants. Mad in America https:\/\/www.madinamerica.com\/2019\/03\/peer-support-groups-right-official-guidelines-wrong-dr-mark-horowitz-tapering-off-antidepressants\/ (2019 accessed 17 February 2020)."},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319884834"},{"key":"e_1_3_3_43_2","first-page":"e48","article-title":"More support and information needed for getting off psych drugs","volume":"3","author":"Giordano T","year":"2011","unstructured":"Giordano T. More support and information needed for getting off psych drugs. J Participat Med 2011; 3: e48.","journal-title":"J Participat Med"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.10603.x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5729"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.2196\/mental.7797"},{"key":"e_1_3_3_47_2","unstructured":"Carville S Ashmore K Cuyas A et al Patients\u2019 experience: review of the evidence on dependence short term discontinuation and longer term withdrawal symptoms associated with prescribed medicines. Rapid Evidence Assessment London: Royal College of Physicians https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/patients-experience (2019 accessed 26 May 2020)."},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320967183"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700070"},{"key":"e_1_3_3_50_2","unstructured":"Vega CP. Cases in deprescribing: when to stop the SSRI. Medscape Psychiatry https:\/\/www.medscape.com\/viewarticle\/910669 (2019 accessed 14 February 2020)."},{"key":"e_1_3_3_51_2","unstructured":"Vega CP. Deprescribing SSRIs: the crowdsourced response. Medscape Psychiatry https:\/\/www.medscape.com\/viewarticle\/912385 (2019 accessed 14 February 2020)."},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319872344."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0712"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.18m02311."},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.2165\/11599450-000000000-00000"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1159\/000506868"},{"key":"e_1_3_3_57_2","first-page":"61","article-title":"The adult SSRI\/SNRI withdrawal syndrome: a clinically heterogeneous entity","volume":"4","author":"Kotzalidis GD","year":"2007","unstructured":"Kotzalidis GD, Patrizi B, Caltagirone SS, et al The adult SSRI\/SNRI withdrawal syndrome: a clinically heterogeneous entity. Clin Neuropsychiatry 2007; 4: 61\u201375.","journal-title":"Clin Neuropsychiatry"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2004.04.010"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.2.151"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.29.051605.113009"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03144.x"},{"key":"e_1_3_3_63_2","first-page":"119","volume-title":"Behavioral neuroscience of drug addiction","author":"D\u2019Souza MS","unstructured":"D\u2019Souza MS, Markou A. Neural substrates of psychostimulant withdrawal-induced anhedonia. In: Self DW, Staley Gottschalk JK (eds) Behavioral neuroscience of drug addiction. Berlin, Heidelberg: Springer, pp. 119\u2013178."},{"key":"e_1_3_3_64_2","unstructured":"Markgraf CG. Introduction to physical dependence and withdrawal. Presented at the safety Pharmacology Society 12th Annual Meeting 1\u20134 October 2012 Phoenix AZ https:\/\/www.safetypharmacology.org\/AM2012\/am12presentations\/Markgraf_IntroPhysicalDependenceWD.pdf (2012 accessed 2 May 2020)."},{"key":"e_1_3_3_65_2","first-page":"3","article-title":"The nature of the discontinuation syndrome associated with antidepressant drugs","volume":"67","author":"Shelton RC","year":"2006","unstructured":"Shelton RC. The nature of the discontinuation syndrome associated with antidepressant drugs. J Clin Psychiatry 2006; 67(Suppl. 4): 3\u20137.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14114"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00045"},{"key":"e_1_3_3_68_2","volume-title":"Concepts of chemical dependency","author":"Doweiko HE","year":"2006","unstructured":"Doweiko HE. Concepts of chemical dependency. 6th ed. Australia: Thomson\/Brooks\/Cole, 2006.","edition":"6"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ptdy.2020.02.020"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6103"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796019000520"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.2166"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30032-X"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2009.10.020"},{"key":"e_1_3_3_76_2","first-page":"169","article-title":"Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?","volume":"15","author":"Heilig M","year":"2010","unstructured":"Heilig M, Egli M, Crabbe JC, et al. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol 2010; 15: 169\u2013184.","journal-title":"et al."},{"key":"e_1_3_3_77_2","first-page":"325","article-title":"Relapse prevention and the five rules of recovery","volume":"88","author":"Melemis SM","year":"2015","unstructured":"Melemis SM. Relapse prevention and the five rules of recovery. Yale J Biol Med 2015; 88: 325\u2013332.","journal-title":"Yale J Biol Med"},{"key":"e_1_3_3_78_2","unstructured":"Substance Abuse and Mental Health Services Administration. Protracted withdrawal. Substance abuse treatment advisory vol. 9 no. 1 Rockville MD: SAMHSA 2010."},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.105.001966"},{"key":"e_1_3_3_80_2","first-page":"255","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria","volume":"25","author":"Black K","year":"2000","unstructured":"Black K, Shea C, Dursun S, et al Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci JPN 2000; 25: 255\u2013261.","journal-title":"J Psychiatry Neurosci JPN"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X701321"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2020.48"},{"key":"e_1_3_3_83_2","first-page":"449","article-title":"Antidepressant discontinuation syndrome","volume":"74","author":"Warner CH","year":"2006","unstructured":"Warner CH, Bobo W, Warner C, et al Antidepressant discontinuation syndrome. Am Fam Physician 2006; 74: 449\u2013456.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.2.1.82"},{"key":"e_1_3_3_85_2","unstructured":"Ashton CH. Benzodiazepines: how they work & how to withdraw (the Ashton manual). Online: Benzodiazepine Information Coalition https:\/\/www.amazon.com\/Benzodiazepines-They-Withdraw-Ashton-Manual-ebook\/dp\/B07QGNP9BL (2002)."},{"key":"e_1_3_3_86_2","article-title":"Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena","volume":"13","author":"Bhanji NH","year":"2006","unstructured":"Bhanji NH, Chouinard G, Kolivakis T, et al Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Can J Clin Pharmacol 2006; 13: e69\u2013e74.","journal-title":"Can J Clin Pharmacol"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb03747.x"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03500.x"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.11.007"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0598"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(03)00528-6"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00240.x"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.3109\/10673229809003578"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1904190"},{"key":"e_1_3_3_95_2","unstructured":"Hall W. Harm reduction guide to coming off psychiatric drugs. New York NY; Northampton MA: Icarus Project and the Freedom Center https:\/\/theicarusproject.net\/resources\/publications\/harm-reduction-guide-to-coming-off-psychiatric-drugs-and-withdrawal\/ (2012)."},{"key":"e_1_3_3_96_2","volume-title":"Your drug may be your problem: how and why to stop taking psychiatric drugs","author":"Breggin PR","year":"1999","unstructured":"Breggin PR, Cohen D. Your drug may be your problem: how and why to stop taking psychiatric drugs. Reading, MA: Perseus Books, 1999."},{"key":"e_1_3_3_97_2","unstructured":"Center for Disease Control and Prevention. Pocket guide: tapering opioids for chronic pain https:\/\/www.cdc.gov\/drugoverdose\/pdf\/clinical_pocket_guide_tapering-a.pdf (2019 accessed 11 December 2019)."},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605040-00006"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30182-8"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-81"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12626"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1080\/17522439.2018.1469163"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.98989"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.3390\/app9153066"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2012-000159"},{"key":"e_1_3_3_106_2","first-page":"452","article-title":"An overview on stability of extemporaneously prepared pharmaceutical suspension","volume":"9","author":"Naveed S","year":"2017","unstructured":"Naveed S, Akhtar F, Khan S. An overview on stability of extemporaneously prepared pharmaceutical suspension. J Bioequivalence Bioavailab 2017; 9: 452\u2013454.","journal-title":"J Bioequivalence Bioavailab"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.171"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-4995-4"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001021"},{"key":"e_1_3_3_110_2","unstructured":"Benzodiazepine Information Coalition. Benzodiazepine tapering strategies and solutions. Benzodiazepine Information Coalition https:\/\/www.benzoinfo.com\/2017\/10\/09\/benzodiazepine-tapering-strategies-and-solutions\/ (2017 accessed 26 March 2020)."},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-018-0313-1"},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001861"},{"key":"e_1_3_3_113_2","first-page":"69","volume-title":"Int J Ment Health Nurs","author":"Salomon C","year":"2014","unstructured":"Salomon C, Hamilton B. Antipsychotic discontinuation syndromes: a narrative review of the evidence and its integration into Australian mental health nursing textbooks: antipsychotic discontinuation syndromes. Int J Ment Health Nurs 2014; 23: 69\u201378."},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119845799"},{"key":"e_1_3_3_115_2","first-page":"76","article-title":"Switching and stopping antidepressants","volume":"39","author":"Keks N","year":"2016","unstructured":"Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr 2016; 39: 76\u201383.","journal-title":"Aust Prescr"},{"key":"e_1_3_3_116_2","unstructured":"British Medical Association. Prescribed drugs associated with dependence and withdrawal \u2013 building a consensus for action https:\/\/www.bma.org.uk\/collective-voice\/policy-and-research\/public-and-population-health\/prescribed-drugs-dependence-and-withdrawal (2015 accessed 16 February 2020)."},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X706001"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18121419"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101016"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2009.02.047"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S110632"},{"key":"e_1_3_3_122_2","unstructured":"Brownlee S Garber J. Medication overload: older Americans are on too many medications. Lown Institute https:\/\/lowninstitute.org\/medication-overload-how-the-drive-to-prescribe-is-harming-older-americans\/ (2019 accessed 6 December 2019)."},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15800"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-02732-2_6"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.2174\/2211556005666160916124719"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2016-000967"},{"key":"e_1_3_3_127_2","first-page":"95","article-title":"The diagnostic clinical interview for drug withdrawal 1 (DID-W1) \u2013 new symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability","volume":"53","author":"Cosci F","year":"2018","unstructured":"Cosci F, Chouinard G, Chouinard V-A, et al The diagnostic clinical interview for drug withdrawal 1 (DID-W1) \u2013 new symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability. Riv Psichiatr 2018; 53: 95\u201399.","journal-title":"Riv Psichiatr"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19com13047"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00126-7"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200603000-00002"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx097"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205426"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2017.1379609"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2016.11.289"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1177\/0897190012467210"},{"key":"e_1_3_3_136_2","first-page":"173","article-title":"Paradoxical and bidirectional drug effects","volume":"35","author":"Smith SW","year":"2012","unstructured":"Smith SW, Hauben M, Aronson JK. Paradoxical and bidirectional drug effects. Drug Saf 2012; 35: 173\u2013189.","journal-title":"Drug Saf"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.11.003"},{"key":"e_1_3_3_138_2","unstructured":"W-BAD World Benzodiazapine Awareness Day. Interdose withdrawal. World Benzodiazapine Awareness Day July 11 https:\/\/w-bad.org\/interdose\/ (2020 accessed 19 February 2020)."},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12706"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1080\/15622970902836022"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.yco.0000165594.60434.84"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03424.x"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr3557w"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0324"},{"key":"e_1_3_3_145_2","first-page":"33","article-title":"A short introduction to pharmacokinetics","volume":"6","author":"Urso R","year":"2002","unstructured":"Urso R, Blardi P, Giorgi G. A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci 2002; 6: 33\u201344.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.4103\/0975-1483.66807"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1990.hed3010634.x"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.2165\/11538280-000000000-00000"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.11.011"},{"key":"e_1_3_3_150_2","first-page":"31","article-title":"Antidepressant noncompliance as a factor in the discontinuation syndrome","volume":"58","author":"Kaplan EM","year":"1997","unstructured":"Kaplan EM. Antidepressant noncompliance as a factor in the discontinuation syndrome. J Clin Psychiatry 1997; 58(Suppl. 7): 31\u201335; discussion 36.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.04.002"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.1159\/000447034"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.256"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.05.029"},{"key":"e_1_3_3_155_2","doi-asserted-by":"publisher","DOI":"10.1159\/000491550"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.17744\/mehc.28.3.9nvtlruygt0r7qca"},{"key":"e_1_3_3_157_2","first-page":"355","article-title":"Antidepressant withdrawal and rebound phenomena","volume":"116","author":"Henssler J","year":"2019","unstructured":"Henssler J, Heinz A, Brandt L, et al Antidepressant withdrawal and rebound phenomena. Dtsch \u00c4rztebl Int 2019; 116: 355\u2013361.","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-019-00649-9"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000000787"},{"key":"e_1_3_3_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(03)00029-9"},{"key":"e_1_3_3_161_2","first-page":"25","article-title":"Kindling in alcohol withdrawal","volume":"22","author":"Becker HC","year":"1998","unstructured":"Becker HC. Kindling in alcohol withdrawal. Alcohol Health Res World 1998; 22: 25\u201333.","journal-title":"Alcohol Health Res World"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.1159\/000477313"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952997809028002"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.12.3.328"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.1177\/074823379901500303"},{"key":"e_1_3_3_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00050-5"},{"key":"e_1_3_3_167_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-295X.112.2.417"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-009-0041-5"},{"key":"e_1_3_3_169_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001049"},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2011.00159"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2011.01.020"},{"key":"e_1_3_3_172_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320970325"},{"key":"e_1_3_3_173_2","doi-asserted-by":"publisher","DOI":"10.1159\/000507227"},{"key":"e_1_3_3_174_2","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.2\/proybyrne"},{"key":"e_1_3_3_175_2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S198774"},{"key":"e_1_3_3_176_2","first-page":"78","article-title":"Help \u2018sensitive\u2019 patients tolerate medication","volume":"8","author":"Neimark G","year":"2009","unstructured":"Neimark G. Help \u2018sensitive\u2019 patients tolerate medication. Curr Psychiatry 2009; 8: 78.","journal-title":"Curr Psychiatry"},{"key":"e_1_3_3_177_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.6.519"},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2011.2764"},{"key":"e_1_3_3_179_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124030-00003"},{"key":"e_1_3_3_180_2","doi-asserted-by":"crossref","unstructured":"Wilson C. People are hacking antidepressant doses to avoid withdrawal. New Scientist https:\/\/www.newscientist.com\/article\/2140106-people-are-hacking-antidepressant-doses-to-avoid-withdrawal\/ (2017 accessed 30 November 2020).","DOI":"10.1016\/S0262-4079(17)31348-9"},{"key":"e_1_3_3_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2015.12.011"},{"key":"e_1_3_3_182_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X683473"},{"key":"e_1_3_3_183_2","doi-asserted-by":"publisher","DOI":"10.1037\/emo0000488"},{"key":"e_1_3_3_184_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.388"},{"key":"e_1_3_3_185_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0716"},{"key":"e_1_3_3_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(84)90028-6"},{"key":"e_1_3_3_187_2","first-page":"435","article-title":"Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia","volume":"49","author":"Dufresne RL","year":"1988","unstructured":"Dufresne RL, Wagner RL. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia. J Clin Psychiatry 1988; 49: 435\u2013438.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_188_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048371"},{"key":"e_1_3_3_189_2","doi-asserted-by":"publisher","DOI":"10.5455\/PBS.20180115111230"},{"key":"e_1_3_3_190_2","first-page":"14","article-title":"SSRI-induced indifference","volume":"7","author":"Sansone RA","year":"2010","unstructured":"Sansone RA, Sansone LA. SSRI-induced indifference. Psychiatry Edgmont 2010; 7: 14\u201318.","journal-title":"Psychiatry Edgmont"},{"key":"e_1_3_3_191_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.me17008ah1c"},{"key":"e_1_3_3_192_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245287"},{"key":"e_1_3_3_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2018.10.020"},{"key":"e_1_3_3_194_2","doi-asserted-by":"publisher","DOI":"10.1080\/0164212X.2016.1165642"},{"key":"e_1_3_3_195_2","unstructured":"Burn W. Wendy burn: medical community must ensure that those needing support to come off anti-depressants can get it. The BMJ Opinion https:\/\/blogs.bmj.com\/bmj\/2020\/09\/25\/wendy-burn-medical-community-must-ensure-that-those-needing-support-to-come-off-anti-depressants-can-get-it\/ (2020 accessed 25 September 2020)."},{"key":"e_1_3_3_196_2","first-page":"7","article-title":"Deprescribing is an essential part of good prescribing","volume":"99","author":"Farrell B","year":"2019","unstructured":"Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician 2019; 99: 7\u20139.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_197_2","unstructured":"Beggelman M. Why do we doctors so often fail to see symptoms are drug side effects? CommonHealth https:\/\/www.wbur.org\/commonhealth\/2016\/12\/30\/doctors-side-effects-medication (2016 accessed 7 March 2020)."},{"key":"e_1_3_3_198_2","first-page":"17","article-title":"Measuring adverse events in psychiatry","volume":"5","author":"Jayaram G","year":"2008","unstructured":"Jayaram G. Measuring adverse events in psychiatry. Psychiatry Edgmont Pa Townsh 2008; 5: 17\u201319.","journal-title":"Psychiatry Edgmont Pa Townsh"},{"key":"e_1_3_3_199_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4185"},{"key":"e_1_3_3_200_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16101158r"},{"key":"e_1_3_3_201_2","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320921694"},{"key":"e_1_3_3_202_2","doi-asserted-by":"publisher","DOI":"10.3122\/15572625-13-6-424"},{"key":"e_1_3_3_203_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2238"},{"key":"e_1_3_3_204_2","first-page":"9","article-title":"American psychiatric association practice guideline for the treatment of patients with major depressive disorder, third edition","volume":"167","author":"Gelenberg A","year":"2010","unstructured":"Gelenberg A, Freeman M, Markowitz J, et al American psychiatric association practice guideline for the treatment of patients with major depressive disorder, third edition. Am J Psychiatry 2010; 167(Suppl. 10): 9\u2013118.","journal-title":"Am J Psychiatry"},{"key":"e_1_3_3_205_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.5.695"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2045125321991274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2045125321991274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2045125321991274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:52:41Z","timestamp":1777593161000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2045125321991274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":204,"alternative-id":["10.1177\/2045125321991274"],"URL":"https:\/\/doi.org\/10.1177\/2045125321991274","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"article-number":"2045125321991274"}}